Shenzhen Chipscreen Biosciences Co EV/EBITDA
What is the EV/EBITDA of Shenzhen Chipscreen Biosciences Co?
The EV/EBITDA of Shenzhen Chipscreen Biosciences Co., Ltd. is 33,216.68
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on SSE compared to Shenzhen Chipscreen Biosciences Co
What does Shenzhen Chipscreen Biosciences Co do?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Companies with ev/ebitda similar to Shenzhen Chipscreen Biosciences Co
- Esaar (India) has EV/EBITDA of 10,213.86
- Sinomax has EV/EBITDA of 11,665.56
- Toyam Industries has EV/EBITDA of 14,862.04
- Aspermont has EV/EBITDA of 20,992.43
- Zall has EV/EBITDA of 25,080.35
- Haina Intelligent Equip Intl has EV/EBITDA of 25,582.84
- Shenzhen Chipscreen Biosciences Co has EV/EBITDA of 33,216.68
- PT Bank Mandiri (Persero) Tbk has EV/EBITDA of 51,302.25
- PT Astra International Tbk has EV/EBITDA of 59,585.87
- PT Bank Rakyat Indonesia (Persero) Tbk has EV/EBITDA of 75,341.59
- PT Semen Indonesia (Persero) Tbk has EV/EBITDA of 97,484.16
- PT XL Axiata Tbk has EV/EBITDA of 142,405.13
- PT Bank Central Asia Tbk has EV/EBITDA of 163,620.10